research
Merck & Co says study shows significantly higher persistence for its arthritis drug Simponi
March 17, 2016Research and Development, Sales and Marketing Merck & Co, drug trial, research, rheumatoid arthritis
US pharma giant Merck & Co (NYSE: MRK) said its rheumatoid arthritis drug showed significantly higher persistence compared with other drugs …
Vitae Pharma soars on positive mid-stage trial results for psoriasis drug
March 17, 2016Business Services, Research and Development, Sales and Marketing Vitae Pharmaceuticals, drug trial, psoriasis, research
Shares in Vitae Pharmaceuticals (Nasdaq: VTAE) nearly doubled in pre-market trading Thursday after the company reported mid-stage trials of its psoriasis …
Shares in Celldex halve in value as it discontinues trial of brain cancer drug
March 8, 2016Manufacturing and Production, Research and Development Cancer, Celldex, research
Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …
The future for pharma packaging
March 1, 2016Manufacturing and Production distribution, packaging, research, supply chain
The pharmaceutical packaging market is projected for strong growth through 2020, driven by innovation for new products and materials and …
Sanofi seals double oncology research deals
January 11, 2016Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research
Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …
Janssen, Enterome and Kymab in research collaborations
January 7, 2016Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research
Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …
The case for adaptive trials in dementia
January 6, 2016Manufacturing and Production, Research and Development Alzheimer's, Alzheimer's disease, adaptive trials, research
An ageing population and widespread chronic neuro-degenerative disease will make dementia an ever increasing burden on society, families and the …
Clinical trials increasingly funded by pharma industry
December 17, 2015Research and Development JAMA, Journal of the American Medical Association, NIH, National Institutes of Health, clinical trials, clinicaltrials.gov, pharma, research
The number of clinical trials funded by pharma has risen significantly since 2006, while the number funded by the US …
Pharma leaders urge UK Government not to cut spending
September 9, 2015Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding
Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …
NICE reworks cancer guidance for GPs
June 23, 2015Sales and Marketing Cancer, GPs, NICE, UK, baker, research
The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …
UK government spends £300 million on dementia
February 23, 2015Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research
UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …
Big pharma spent $112 billion on R&D in 2013
December 17, 2014Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research
The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …
Cell Therapy Catapult to build £55 million bioscience campus
December 17, 2014Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage
UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …
UK government and partners pay £230m for disease research
October 23, 2014Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research
A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …
Mayor of London calls for dementia R&D centre
October 8, 2014Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research
The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
